Skip to main content Skip to Navigation menu Skip to Login form
Skip to main content Skip to top of page
Skip to Navigation menu Skip to top of page
Case law surrounding grey market goods is still developing in the United States, but Ronald Dove and Hope Hamilton suggest some practical strategies for successfully preventing their importation and distribution
The Federal Circuit last month ruled that the ITC could not extend a limited exclusion order barring the import of Qualcomm chips found to infringe Broadcom's patent to downstream products
Pharmaceutical companies are adopting new IP strategies to stay competitive. Rakesh Mishra and GVS Sesha Kumar review some of the most successful examples
Brands such as Wal-Mart and Mattel have suffered from problems caused by foreign manufacturers. Oliver Herzfeld and Richard Bergovoy provide some guidance on how to minimise the risks
Taiwan's Intellectual Property Office is to amend the compulsory licensing provisions of its Patent Law after a long-running dispute between a local CD maker and Philips finally ended
The Supreme Court's decision in Quanta v LG could make it harder for licensors to collect downstream royalties. Eileen McDermott explores the implications
China's long-awaited Anti-Monopoly law comes into effect on August 1, but its impact on IP owners is far from certain, explain Kirstie Nicholson and Zirou Liu
IP licensing is a key tool in any company's belt. But several recent Supreme Court decisions could make the process trickier, say Edward E Vassallo and Swatee Jasoria
Procter & Gamble, Max Planck Innovation and the Catholic University of Leuven have been recognized for their achievements in technology transfer
It has been just over three decades since the first biotechnology company - Genentech - was formed in 1976. Since then biotechnology has become a multi-billion dollar industry with ground-breaking products, based on original research. Eklavya Gupte examines five patents that have shaped the sector
Interview: As Microsoft's global vice-president of IP and licensing, Horacio Gutierrez plays an integral role in protecting the company's IP rights
A court in Taipei has overturned a decision by the local IP office to grant compulsory licences to a Taiwanese company for five patents owned by Philips
Thailand's new government has sent out mixed signals on whether it will continue with a controversial compulsory licence programme for pharmaceuticals
Microsoft has promised to make it easier for rival businesses to make products that are interoperable with its own software
The UK High Court has made its first declaration of non-essentiality (DONE) in a patent dispute between two telecoms companies
The US Supreme Court has heard oral arguments in the closely watched patent exhaustion case Quanta Computer v LG Electronics
A UN Guide on secured transactions has been changed following concerns about its impact on IP. Ben Goodger provides an inside view of the lobbying campaign
In September, Managing IP organized a web seminar on the latest trends in technology licensing in association with Greenberg Traurig. James Nurton reports
Nokia's Tim Frain brings to the presidency of TMPDF battle scars from the debate over the CII directive. James Nurton spoke to him about patent policy, phone standards and the IP triangle
What impact will September's Microsoft ruling have on IP owners in Europe? Helen Davison reports
Managing IP and Ocean Tomo invited IP practitioners to discuss strategies, legal trends and other issues relating to the increasingly important topic of patent sales, acquisitions and valuation
The recent US-Korea trade deal could lead to many more US banks applying for patents to protect their business methods in Korea. This is how local banks are responding
The Court of First Instance's recent antitrust decision against Microsoft could affect the way in which many more companies license their IP rights
Ethiopia's success in trade marking its coffee has encouraged more countries to consider IP protection for assets previously considered commodities
The most sophisticated finance companies are now using IP as a growth driver. Managing IP provides an IP guide for banks
Canada's Supreme Court has ruled that copyright law cannot be used to stop parallel imports where the copyright rights have been exclusively licensed
Oliver Herzfeld and Richard Bergovoy complete their guide to negotiating successful licence agreements
US coffee shop chain Starbucks and the Ethiopian government have called an end to their public relations war
Danone's spat with joint venture partner Wahaha has highlighted the risks of investing in China. Peter Ollier examines what went wrong
Carefully crafted trade mark licences can enrich licensors and licensees, say Oliver Herzfeld and Richard Bergovoy
The boom in mergers, acquisition and private equity investment puts the onus on investors to carry out comprehensive IP due diligence. Tamsen Valoir provides a practical 10-point plan covering the most important questions to ask
After the Thai public health ministry said it would issue a compulsory licence over a patent held by Merck, the Brazilian government has followed suit
The US has, until now, been the preferred habitat of the patent troll. But assertive licensing companies are becoming increasingly aware of how they can use Europe's fragmented system of patent rules to their negotiating advantage, explain William Cook and Dafydd Bevan
The US Supreme Court decision in MedImmune gave licensees the right to challenge a licensed patent while continuing to pay royalties. But those patent owners that are responding to the new challenge by redrafting their licences must pay close attention to EU competition rules, say Sangeeta Puran and David Fyfield
A company at the heart of the controversy over compulsory licensing for pharmaceuticals in Thailand is to reduce the price it charges for one of its key drugs
Deals between patent owners and open source distributors using the GNU General Public Licence version 3 would be blocked if the latest draft of the GPL is adopted
The MedImmune case transformed the relationship between patent licensors and licensees. Nicholas Groombridge considers whether it will lead to a wave of patent invalidation lawsuits
At the second annual IPTEC meeting, held last month, technology licensors and licensees got together to share experiences and discuss business opportunities. James Nurton reports from Cannes, France
MIP, in association with Finnegan Henderson, invited three brand owners as well as lawyers from the US, China and Germany to discuss how to protect and manage brands internationally. Topics covered included famous marks, new types of marks, the Madrid Protocol, transliterations and other means of protecting brands
Emma Barraclough, London
Brand pharmaceutical companies sometimes agree to share profits from their patented drugs with generic manufacturers to keep rival products off the market. James Walsh and Lisa Huett consider the legality of these so-called reverse payments under Australian law in light of increasing attacks from antitrust authorities overseas
Subscriber login:
CURRENT ISSUE:
December 2008 / January 2009
COVER STORY: The IP world goes flat
Companies can save a lot of money by outsourcing their IP work, but it takes time and effort to get the process right. Peter Ollier assesses the options
CURRENT ISSUE: